BioNTech says it will start cancer vaccine trials in the UK from September
The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.
Source link
- Türkiye’s biggest cities facing drought amid insufficient rainfall
- Nonfarm payrolls rose 223,000 in December, as strong jobs market tops expectations
